Sema – GLP-1 Research Peptide

Sema. (glutide) is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist developed for laboratory investigation of incretin-mediated glucose homeostasis, insulin secretion pathways, and metabolic signaling mechanisms. This modified peptide analog has been extensively characterized for receptor binding kinetics, intracellular signaling cascade activation, and glucose-dependent insulin secretion in pancreatic β-cell models under controlled research conditions.

Research Applications:

• GLP-1 receptor pharmacology and binding affinity characterization
• cAMP signaling pathway activation and kinetics studies
• Insulin secretion pathway investigation in β-cell models
• Glucose-stimulated insulin release (GSIS) mechanism research
• Receptor internalization and desensitization kinetics
• Peptide stability profiling (pH, temperature, storage conditions)
• Analytical method development for GLP-1 analog quantification
• Structure-activity relationship studies comparing GLP-1 analogs

Specifications:

• Purity: >98% (HPLC verified)
• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
• Molecular Weight: 4113.58 g/mol
• CAS Number: 910463-68-2
• Supplied as: Lyophilized powder in sealed vials
• Available doses: 5mg, 10mg, 20mg
• Storage: -20°C, protect from light and moisture
• Each batch includes Certificate of Analysis (COA)

Manufactured under GMP-compliant conditions with rigorous quality control for reproducibility in GLP-1 receptor research.

For laboratory research use only. Not for human consumption.